Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Michael A. Nauck"'
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Cardiovascular outcomes trials (CVOTs) with novel drugs to treat type 2 diabetes have uniformly chosen the composite “major adverse cardiovascular events (MACE)” as their primary endpoint, but they also report hazard ratios for individua
Externí odkaz:
https://doaj.org/article/7f7efbf9353e4f0f80056a38b2d032c7
Publikováno v:
Scientific reports. 12(1)
Cardiovascular outcomes trials (CVOTs) with novel drugs to treat type 2 diabetes have uniformly chosen the composite "major adverse cardiovascular events (MACE)" as their primary endpoint, but they also report hazard ratios for individual cardiovascu